Cargando…

Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome

Objective: The aim of this study was to analyze and compare the differential expression of peptides within the follicular fluid of polycystic ovary syndrome (PCOS) patients versus normal women by using peptidomics techniques. The underlying mechanisms involved in PCOS pathogenesis will be explored,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ningyu, Chen, Yuanyuan, Lu, Lu, Yan, Hua, Zhou, Jing, Li, Kai, Zhang, Wuwen, Yuan, Lihua, Heng, Boon Chin, Zeng, Weiwei, Shi, Yin, Tong, Guoqing, Yin, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666747/
https://www.ncbi.nlm.nih.gov/pubmed/38020909
http://dx.doi.org/10.3389/fcell.2023.1289063
_version_ 1785139108838899712
author Sun, Ningyu
Chen, Yuanyuan
Lu, Lu
Yan, Hua
Zhou, Jing
Li, Kai
Zhang, Wuwen
Yuan, Lihua
Heng, Boon Chin
Zeng, Weiwei
Shi, Yin
Tong, Guoqing
Yin, Ping
author_facet Sun, Ningyu
Chen, Yuanyuan
Lu, Lu
Yan, Hua
Zhou, Jing
Li, Kai
Zhang, Wuwen
Yuan, Lihua
Heng, Boon Chin
Zeng, Weiwei
Shi, Yin
Tong, Guoqing
Yin, Ping
author_sort Sun, Ningyu
collection PubMed
description Objective: The aim of this study was to analyze and compare the differential expression of peptides within the follicular fluid of polycystic ovary syndrome (PCOS) patients versus normal women by using peptidomics techniques. The underlying mechanisms involved in PCOS pathogenesis will be explored, together with screening and identification of potential functional peptides via bioinformatics analysis. Materials and methods: A total of 12 patients who underwent in vitro fertilization and embryo transfer (IVF-ET) at the Reproductive Medicine Center of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from 1 September 2022 to 1 November 2022 were included in this study. The follicular fluid of PCOS patients (n = 6) and normal women (n = 6) were collected. The presence and concentration differences of various peptides were detected by the LC-MS/MS method. GO and KEGG analysis were performed on the precursor proteins of the differentially-expressed peptides, and protein network interaction analysis was carried out to identify functionally-relevant peptides among the various peptides. Results: A variety of peptides within the follicular fluid of PCOS versus normal patients were detected by peptidomics techniques. Altogether, 843 upregulated peptides and 236 downregulated peptides were detected (absolute fold change ≥2 and p < 0.05). Of these, 718 (718 = 488 + 230) peptides were only detected in the PCOS group, while 205 (205 = 174 + 31) were only detected in the control group. Gene Ontology enrichment and pathway analysis were performed to characterize peptides through their precursor proteins. We identified 18 peptides from 7 precursor proteins associated with PCOS, and 4 peptide sequences were located in the functional domains of their corresponding precursor proteins. Conclusion: In this study, differences in the follicular development of PCOS versus normal patients were revealed from the polypeptidomics of follicular development, which thus provided new insights for future studies on the pathological mechanisms of PCOS development.
format Online
Article
Text
id pubmed-10666747
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106667472023-01-01 Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome Sun, Ningyu Chen, Yuanyuan Lu, Lu Yan, Hua Zhou, Jing Li, Kai Zhang, Wuwen Yuan, Lihua Heng, Boon Chin Zeng, Weiwei Shi, Yin Tong, Guoqing Yin, Ping Front Cell Dev Biol Cell and Developmental Biology Objective: The aim of this study was to analyze and compare the differential expression of peptides within the follicular fluid of polycystic ovary syndrome (PCOS) patients versus normal women by using peptidomics techniques. The underlying mechanisms involved in PCOS pathogenesis will be explored, together with screening and identification of potential functional peptides via bioinformatics analysis. Materials and methods: A total of 12 patients who underwent in vitro fertilization and embryo transfer (IVF-ET) at the Reproductive Medicine Center of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from 1 September 2022 to 1 November 2022 were included in this study. The follicular fluid of PCOS patients (n = 6) and normal women (n = 6) were collected. The presence and concentration differences of various peptides were detected by the LC-MS/MS method. GO and KEGG analysis were performed on the precursor proteins of the differentially-expressed peptides, and protein network interaction analysis was carried out to identify functionally-relevant peptides among the various peptides. Results: A variety of peptides within the follicular fluid of PCOS versus normal patients were detected by peptidomics techniques. Altogether, 843 upregulated peptides and 236 downregulated peptides were detected (absolute fold change ≥2 and p < 0.05). Of these, 718 (718 = 488 + 230) peptides were only detected in the PCOS group, while 205 (205 = 174 + 31) were only detected in the control group. Gene Ontology enrichment and pathway analysis were performed to characterize peptides through their precursor proteins. We identified 18 peptides from 7 precursor proteins associated with PCOS, and 4 peptide sequences were located in the functional domains of their corresponding precursor proteins. Conclusion: In this study, differences in the follicular development of PCOS versus normal patients were revealed from the polypeptidomics of follicular development, which thus provided new insights for future studies on the pathological mechanisms of PCOS development. Frontiers Media S.A. 2023-11-08 /pmc/articles/PMC10666747/ /pubmed/38020909 http://dx.doi.org/10.3389/fcell.2023.1289063 Text en Copyright © 2023 Sun, Chen, Lu, Yan, Zhou, Li, Zhang, Yuan, Heng, Zeng, Shi, Tong and Yin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Sun, Ningyu
Chen, Yuanyuan
Lu, Lu
Yan, Hua
Zhou, Jing
Li, Kai
Zhang, Wuwen
Yuan, Lihua
Heng, Boon Chin
Zeng, Weiwei
Shi, Yin
Tong, Guoqing
Yin, Ping
Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
title Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
title_full Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
title_fullStr Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
title_full_unstemmed Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
title_short Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
title_sort peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666747/
https://www.ncbi.nlm.nih.gov/pubmed/38020909
http://dx.doi.org/10.3389/fcell.2023.1289063
work_keys_str_mv AT sunningyu peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT chenyuanyuan peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT lulu peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT yanhua peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT zhoujing peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT likai peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT zhangwuwen peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT yuanlihua peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT hengboonchin peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT zengweiwei peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT shiyin peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT tongguoqing peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome
AT yinping peptidomicanalysisoffollicularfluidinpatientswithpolycysticovariansyndrome